Calcivet Solution for Injection for Cattle

Երկիր: Իռլանդիա

Լեզու: անգլերեն

Աղբյուրը: HPRA (Health Products Regulatory Authority)

Ակտիվ բաղադրիչ:

Calcium gluconate; Boric acid; Magnesium hypophosphite hexahydrate

Հասանելի է:

Norbrook Laboratories (Ireland) Limited

ATC կոդը:

QA12A

INN (Միջազգային անվանումը):

Calcium gluconate; Boric acid; Magnesium hypophosphite hexahydrate

Դոզան:

332, 68, 30 milligram(s)/millilitre

Դեղագործական ձեւ:

Solution for injection

Ռեկվիզորի տեսակը:

LR: Licensed Retailer as defined in national legislation

Թերապեւտիկ տարածք:

CALCIUM

Լիազորման կարգավիճակը:

Authorised

Հաստատման ամսաթիվը:

2000-10-02

Ապրանքի հատկությունները

Health Products Regulatory Authority
30 January 2019
CRN008TJD
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Calcivet Solution for Injection for Cattle
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
​
ACTIVE SUBSTANCES:
​
​
Calcium Gluconate
​
332 mg
​
Boric Acid
​
68 mg
​
Magnesium hypophosphite hexahydrate
​
30 mg
EXCIPIENTS:
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection.
A clear pale yellow aqueous solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calcivet is indicated in the treatment of hypocalcaemia complicated by
deficiency of
magnesium.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Health Products Regulatory Authority
30 January 2019
CRN008TJD
Page 2 of 4
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
The solution should be warmed to body temperature before
administration.
Intravenous injections should be given slowly and stopped on the first
signs of
adverse reaction. Rapid intravenous injection may result in cardiac
arrhythmias and in
severely toxaemic animals collapse and death.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY
MEDICINAL PRODUCT TO ANIMALS
None.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
Calcivet can be safely administered to pregnant and lactating animals.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTIONS
None.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by subcutaneous or slow intravenous injection.
Cattle: 150 - 400 ml
4.10 OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF
NECESSARY
Not applicable.
4.11 WITHDRAWAL PERIOD(S)
Meat and offal: zero days
Milk: zero hours
5 PHARMACOLOGICAL OR IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Alimentary tract and metabolism, mineral
supplements;
calcium
ATC vet co